UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
(Mark One)
☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2019;
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-38161
Calyxt, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
| 27-1967997 |
(State or other jurisdiction of |
| (I.R.S. Employer |
incorporation or organization) |
| Identification No.) |
|
| |
2800 Mount Ridge Road |
|
|
Roseville, MN |
| 55113-1127 |
(Address of principal executive offices) |
| (Zip Code) |
(651) 683-2807
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
|
|
|
|
|
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
|
| ||
Common Stock (0.0001 par value) |
| CLXT |
| The NASDAQ Global Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act:
|
|
|
|
|
|
|
Large accelerated filer |
| ☐ |
| Accelerated filer |
| ☑ |
Non-accelerated filer |
| ☐ |
| Smaller reporting company |
| ☐ |
|
|
|
| Emerging growth company |
| ☑ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☑ No
As of August 6, 2019, there were 32,866,100 shares of common stock, $0.0001 par value per share, outstanding.
Calyxt, Inc. (the “Company”) is filing this Amendment No. 1 (this “Amendment No. 1”) to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, which was originally filed on August 7, 2019 (the “Original Filing”) for the sole purpose of furnishing Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this Amendment No. 1 provides the XBRL (eXtensible Business Reporting Language) data associated with the Original Filing.
Other than the addition of Exhibit 101, no other changes have been made to the Original Filing.
This Amendment No. 1 does not reflect events that may have occurred subsequent to the filing date of the Original Filing and does not modify or update in any way disclosures made in the Original Filing.
| (a) | Index of Exhibits |
Exhibit Number |
| Description | |
3.1 |
|
| |
3.2 |
|
| |
10.1 |
|
| |
31.1* |
|
| |
31.2* |
|
| |
32* |
|
| |
101.INS* |
| XBRL Instance Document |
|
101.SCH* |
| XBRL Taxonomy Extension Schema Document |
|
101.CAL* |
| XBRL Taxonomy Extension Calculation Linkbase Document |
|
101.DEF* |
| XBRL Taxonomy Extension Definition Linkbase Document |
|
101.LAB* |
| XBRL Taxonomy Extension Label Linkbase Document |
|
101.PRE* |
| XBRL Taxonomy Extension Presentation Linkbase Document |
|
*Filed herewith
†Indicates management contract or compensatory plan
2
Pursuant to the requirements of the Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on August 7, 2019.
|
|
|
CALYXT, INC. | ||
|
| |
By: |
| /s/ James A. Blome |
Name: |
| James A. Blome |
Title: |
| Chief Executive Officer (Principal Executive Officer) |
|
| |
By: |
| /s/ William F. Koschak |
Name: |
| William F. Koschak |
Title: |
| Chief Financial Officer (Principal Financial and Accounting Officer) |
3